Suppr超能文献

门静脉-肠道引流式胰肾联合移植:一例报告

Simultaneous pancreas-kidney transplantation with portal-enteric drainage: a case report.

作者信息

Qin Ke-Wang, Jie Zhi-Gang, Wang Gong-Xian, Chang Yu-Lan, Zhang Hong-Yan, Cao Jian-Ping, Chen Xiao-Hua, Peng Zhi-Hai

机构信息

Department of General Surgery, First Affiliated Hospital of Jiangxi Medical College, Nanchang 330006, China.

出版信息

Hepatobiliary Pancreat Dis Int. 2004 Nov;3(4):620-2.

Abstract

BACKGROUND

Simultaneous pancreas-kidney transplantation (SPK) with portal-enteric drainage is physiological effective in treatment of patients with diabetes mellitus complicated by end-stage renal disease. A case is reported with a review of our clinical experience.

METHODS

A patient with type 2 diabetes complicated by renal failure was subjected to SPK transplantation with portal-enteric drainage. Pancreaticoduodenal allograft procured from corpse was transplanted to recipient's right abdomen with donor's portal vein anastomosed to recipient's superior mesenteric vein. Donor's plastic pancreas artery was anastomosed to recipient's right common iliac artery and donor's duodenum anastomosed to recipient's jejunum. The kidney allograft was transplanted ectopically to the contralateral iliac fossa. Postoperative immunosuppression includes tacrolimus (TAC)/mycophenolate mofetil (MMF)-based regimen and methylprednisolone or prednisone.

RESULTS

On the 5th postoperative day, the level of blood creatinine decreased from 590 micromol/L to normal. Daily urine volume was about 2500 ml. On the 18th postoperative day, insulin was given up, and the levels of fasting blood-glucose and after meal blood-glucose were kept normal. No acute rejection symptoms or other complications were observed except infection of Pseudomonas aeruginosa.

CONCLUSION

Combined pancreas and kidney transplantation with portal-enteric drainage is a physiological effective treatment for diabetic patients with end-stage renal disease.

摘要

背景

门静脉-肠道引流的同期胰肾联合移植(SPK)在治疗糖尿病合并终末期肾病患者方面具有生理有效性。现报告1例病例并回顾我们的临床经验。

方法

1例2型糖尿病合并肾衰竭患者接受了门静脉-肠道引流的SPK移植。将取自尸体的胰十二指肠移植物移植到受者右下腹,供者门静脉与受者肠系膜上静脉吻合。供者的人工胰腺动脉与受者右髂总动脉吻合,供者十二指肠与受者空肠吻合。肾移植物异位移植到对侧髂窝。术后免疫抑制包括以他克莫司(TAC)/霉酚酸酯(MMF)为基础的方案以及甲泼尼龙或泼尼松。

结果

术后第5天,血肌酐水平从590微摩尔/升降至正常。每日尿量约2500毫升。术后第18天,停用胰岛素,空腹血糖和餐后血糖水平保持正常。除铜绿假单胞菌感染外,未观察到急性排斥反应症状或其他并发症。

结论

门静脉-肠道引流的胰肾联合移植是治疗糖尿病合并终末期肾病患者的一种生理有效的方法。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验